ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myhre, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myhre, B.
Annals of Clinical and Laboratory Science, Vol 13, Issue 2, 143-149
Copyright © 1983 by Association of Clinical Scientists


Articles

Problems in crossmatching blood from cancer patients

BA Myhre

The term "cancer" is an umbrella for a large number of malignant diseases which vary in severity and type. Therefore, many problems are associated with crossmatching a patient with this diagnosis. Blood use may vary greatly in amount and in the urgency of its need. The diseases themselves may cause cold reactive auto agglutinins to appear. The diseases and their treatments may cause red cell antigenic structure to be modified or antibodies to decrease in strength. Multiple transfusions may induce the formation of multiple antibodies. A few blood groups have been associated with a higher incidence of carcinoma in the patients possessing them. All of these possibilities must be considered by the blood bank when a transfusion request for a patient with "cancer" is received.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the Association of Clinical Scientists.